Entrada Therapeutics
TRDA
#6079
Rank
A$1.10 B
Marketcap
$29.50
Share price
-4.61%
Change (1 day)
11.76%
Change (1 year)

Entrada Therapeutics (TRDA) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$0.20 Billion

According to Entrada Therapeutics's latest financial reports the company's total liabilities are A$0.20 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Entrada Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.33 B473.56%
2022-12-31A$58.04 M491.48%
2021-12-31A$9.81 M-91.12%
2020-12-31A$0.11 B129.33%
2019-12-31A$48.21 M